Skip to main content
AMRZ logo

AMRZ · Amrize Ltd

Track AMRZ — free
$40.52 -0.37 (-0.90%) At close · Nov 16
Market Cap
$21.57B
Shares
532.39M
Volume · Nov 16 2.97M Avg daily vol (3M) 4.07M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$40.52 Open$40.21 Day$39.99–40.78 52W close$36.09–65.86 Avg vol 30d4.0M Short int14.8M · 2.8% of shares · 3.0d Short vol57% Last earningsOct 29, 2026 DataJun 2025–Nov 2026 Filing10-Q · Oct 29

Up next

Feb 16, 2027 Est · unconfirmed · in 13 wks

Latest documents

2026
Oct 29
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Quarterly report for FY2026 Q3

Amrize Ltd reported nine-month revenues of $9,445 million, net income of $927 million, Adjusted EBITDA of $2,253 million and operating cash flow of $222 million for the nine months ended September 30, 2026; operating cash flow declined from $417 million in 2025.

Revenue $3.77B ▲ 2.2% Net income $559M ▲ 3.1% Diluted EPS $1.02 ▲ 4.1%
Read from the MD&A section
Oct 28
Current report 8-K
Financial results, Regulation FD disclosure

Amrize reported third-quarter revenues of $3,771 million, up 2.2%; net income of $558 million, up 3.3%; and Adjusted EBITDA of $1,076 million, up 0.2%. The Board declared a $0.11 per share third-quarter dividend payable November 18, 2026.

Read from the first part of this long document
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$12.26B
Trailing 12 months
Net income (TTM)
$1.26B
Trailing 12 months
Revenue growth YoY
+2.2%
Year over year
Operating margin
15.5%
Trailing 12 months
P / E (TTM)
18.0
Trailing earnings · reciprocal yield 5.6%
FCF yield
4.9%
TTM · current market cap
Return on invested capital
8.6%
Trailing 12 months
Net cash
−$4.64B
Latest balance sheet
Dividend yield
1.9%
Trailing 12 months
Shares change YoY
-1.5%
Year over year · fewer shares
Price change (1Y)
-17.8%
Trailing year
Short interest
2.8%
Latest settlement · 3.0 days to cover
View all 125 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Weak Sentiment Neutral Fundamentals Fair Quant / Vol High
Market backdrop VIX 19.3 · elevated Equity put/call 0.63
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −19%
below
Price vs 50-day avg +3%
above
RSI (14) 49
neutral
MACD trend Negative
52-week position 15%
near low
Momentum
relative strength
Weak
1-month return +7%
trailing
6-month return −24%
trailing
YTD return −25%
this year
Relative strength −22%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $39 › 200d $50 — 200d above 50d
Institutional flow Distributing
-19% holders QoQ · +46 funds added
Insider flow Accumulating
Net +$1.7M over 90 days · 0% sells
Short interest Rising
2.78% of shares out · ▲ +17.3% MoM · 3.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
381 holders — mid 1-yr range
Squeeze score 56
elevated · 0–100
Fundamentals
Fair
Revenue growth +1%
Y/Y
Gross margin 26%
contracting
EPS growth −7%
Y/Y
Free cash flow $1.4B
Valuation P/E 17.9
below peers
Balance sheet $3.3B
net debt
Quant / Vol
risk profile
High
Volatility 38%
annualized · 1-yr
Max drawdown −45%
past year
ATR 3.1%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the 8-K filed Aug 6, 2026
Full Year 2026
Revenues Raised $12.5B – $12.7B
Apr 29, 2026 $12.29B – $12.52B changed to Aug 6, 2026 $12.5B – $12.7B
prior FY $11.82B midpoint +6.6% Y/Y
Adjusted EBITDA Non-GAAP Lowered $3.1B – $3.2B
Apr 29, 2026 $3.25B – $3.34B changed to Aug 6, 2026 $3.1B – $3.2B
2026
Capital Expenditures Maintained $900M
Apr 30, 2026 $900M changed to Aug 6, 2026 $900M
Interest Expense, Net Maintained $340M
Apr 29, 2026 $340M changed to Aug 6, 2026 $340M
Adjusted Effective Tax Rate Non-GAAP 23% – 25%
Corporate Costs Maintained $200M
Apr 29, 2026 $200M changed to Aug 6, 2026 $200M
FY 2026
Capex $900M
Previous outlook earlier release · from the Earnings Call filed Apr 30, 2026

Still-open targets the latest release did not restate under the same label.

Net interest expense · full year $340M
Revenues to grow · full year 2026 4% – 6%
Prior guidance period ended · from the Earnings Call filed Apr 30, 2026
Price increase for Q2 · Q2 5%
Guided vs delivered · last 1 settled
Revenues 2025
guided $11.7B – $12B
$11.82B In line

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell
3 · 2 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−19% Bearish
Price vs 50-day avg
+3% Bullish
RSI (14)
49 Neutral
MACD trend
Negative Bearish
52-week position
15% Bearish
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $39 › 200d $50 — 200d above 50d
Institutional flow Distributing
-19% holders QoQ · +46 funds added
Insider flow Accumulating
Net +$1.7M over 90 days · 0% sells
Short interest Rising
2.78% of shares out · ▲ +17.3% MoM · 3.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
381 holders — mid 1-yr range
Price context
position in its 52-week range
Range low $36 Now $41 · 15% Range high $66
vs 200-day avg -19% vs 50-day avg +3%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Building Envelope segment share of revenues 30% the three months ended June 30, 2026 filing —
EBITDA non-GAAP $968M For the three months ended June 30, 2026 filing —
GAAP → non-GAAP reconciliation
GAAP Net income 476M
+257M Depreciation, depletion, accretion and amortization
+89M Interest expense, net
+146M Income tax expense
= EBITDA 968M
EBITDA Margin non-GAAP 27.7% For the three months ended June 30, 2026 filing —
Total capital expenditures $244M the three months ended June 30, 2026 filing —
Total lease expense $100M the three months ended June 30, 2026 filing —
Adjusted Diluted Earnings per Share non-GAAP $0.74 six months ended June 30, 2026 —
Adjusted EBITDA non-GAAP $3.02B trailing twelve months ended June 30, 2026 —
Adjusted EBITDA Margin non-GAAP 20.8% six months ended June 30, 2026 —
Aggregates - price per ton $14.67 three months ended June 30, 2026 —
Aggregates - tons sold 34.3M three months ended June 30, 2026 —
ASPIRE Savings non-GAAP $29M Q2 2026 —
Building Envelope Segment Adjusted EBITDA non-GAAP $318M six months ended June 30, 2026 —
Building Envelope Segment Adjusted EBITDA margin non-GAAP 22.6% Q2 2026 —
Building Materials Segment Adjusted EBITDA non-GAAP $960M six months ended June 30, 2026 —
Capital expenditures $241M second quarter of 2026 —
Cement - price per ton $171.43 three months ended June 30, 2026 —
Cement - tons sold 6.3M three months ended June 30, 2026 —
Dividends Paid $305M Q2 2026 —
Free Cash Flow non-GAAP -$986M six months ended June 30, 2026 —
Net Debt non-GAAP $5.28B As of June 30, 2026 —
Segment Adjusted EBITDA margin non-GAAP 32.4% three months ended June 30, 2026 —
Share Repurchases $197M Q2 2026 —
Total Cash Returned to Shareholders $502M Q2 2026 —
Total Segment Adjusted EBITDA non-GAAP $1.28B six months ended June 30, 2026 —
Unallocated corporate costs non-GAAP $100M six months ended June 30, 2026 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Building Materials — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
AMRZ
Amrize Ltd
this stock
$21.57B -25.1% +0.9% 17.9 2.8%
CRH
Crh Public Ltd Co
$61.45B -26.0% +5.3% 17.4 2.1%
MLM
Martin Marietta Materials Inc
$36.30B -18.0% +8.6% 13.5 4.7%
VMC
Vulcan Materials CO
$35.58B -2.8% +6.4% 32.9 2.9%
JHX
James Hardie Industries plc
$15.83B +31.2% +24.7% — 3.9%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
381
% held
36.4%
Net QoQ
-63.5M sh
Top holder
VANGUARD CAPITAL MANAGEME…
Held Float
View
Held by Funds
Fund positions
80
View
Short & Settlement
Short Interest Rising
Shares short
14.8M
Days to cover
3.0d
Change
+2.2M sh
View
Short Volume
Short vol %
57%
As of
Nov 16, 2026
Short Total
View
Fails to Deliver
FTD shares
2.3K
Value
$97.3K
As of
Oct 30, 2026
View
Off-Exchange
Off-exchange %
40.7%
Week of
Oct 12, 2026
Off-exch Lit
View
Smart Money
Insider Trades Cluster buy
Net (90d)
+$1.7M
Buyers / Sellers
5 / 0
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$11.8B
Net income (FY)
$1.2B
EPS diluted
$2.14
View
Buybacks
Authorized
shares 26.7M
View
Filings
SEC Filings
Latest
10-Q
Filed
Oct 29, 2026
This year
22

Amrize Ltd reported nine-month revenues of $9,445 million, net income of $927 million, Adjusted EBITDA of $2,253 million and operating cash flow of $222 million for the nine months ended September 30, 2026; operating cash flow declined from $417 million in 2025.

View
Earnings & Events
Webcasts
Last webcast
Oct 30, 2026
View
Investor Relations
Latest news
Amrize Reports Third Quarter 2026…
Published
Oct 28, 2026
View

Performance

5D 20D 120D MTD YTD
AMRZ -5.4% +6.7% -23.7% -2.1% -25.1%
SPY -1.7% -3.5% -1.4% -2.1% +8.5%
vs SPY -3.7% +10.1% -22.3% +0.0% -33.6%

Capital returns

Latest dividend
$0.11 / share · ex Nov 10, 2026
Cut 75%
Paid (TTM)
$0.77 / share · 4 payouts
Dividend yield (TTM, derived)
1.90%
Full dividend history
Buyback program · as of Sep 30, 2026
Authorized
shares 26.70M
Spent (derived)
—
Remaining
—

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 2035989 CUSIP H2927K103 13F (30d) 353 filings 344 filers Visit website Investor relations